Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in ...

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Learn about Brink Therapeutics as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

Learn about metabolomics, biology's fourth language that has remained vastly untapped up until now and could accelerate ...

Find out why Europe has fallen behind the U.S. and China in the AI race in biotech and what it needs to do to catch up.

Find out what makes Basel's biotech hub so successful, as it has cemented its place as one of Europe's brightest life ...

For decades, cystic fibrosis has remained a relentless, life-limiting disease. But now, the future of cystic fibrosis care could be shifting from symptom management to something far more revolutionary ...